PerkinElmer finalizes Caliper Life Sciences acquisition

Nov. 8, 2011
PerkinElmer (NYSE: PKI) has finalized its acquisition of imaging and detection solutions provider Caliper Life Sciences (NASDAQ: CALP).

PerkinElmer (NYSE: PKI; Waltham, MA) has finalized its acquisition of imaging and detection solutions provider Caliper Life Sciences (NASDAQ: CALP; Hopkinton, MA). In September, PerkinElmer announced its intent to acquire Caliper for $10.50 per share, for a total net purchase price of approximately $600 million in cash.

The acquisition looks to strengthen PerkinElmer's position in personalized medicine, says Robert F. Friel, PerkinElmer chairman and CEO, and provide expanded offerings across the company's biomedical, diagnostics, environmental, and food safety end-markets.

Also, PerkinElmer has named Kevin Hrusovsky, who was Caliper’s CEO, as the head of a newly combined $500 million business that integrates the former Caliper organization with PerkinElmer’s existing research business.

Sponsored Recommendations

March 31, 2025
Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
March 31, 2025
Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
March 31, 2025
Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
March 31, 2025
Explore the essential role of optical filters in enhancing Raman spectroscopy measurements including the various filter types and their applications in improving signal-to-noise...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!